Fulcrum Therapeutics (FULC) Operating Leases (2022 - 2026)
Fulcrum Therapeutics (FULC) recorded Operating Leases of $2.76 million in Q2 2026, down 47.7% from $5.28 million a year earlier and down 19.0% from the prior quarter.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) Operating Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Fulcrum Therapeutics reported Operating Leases of $4.04 million, down 37.3% from FY2024.
- Annual Operating Leases has declined for three straight years, with a three-year compound annual growth rate of -28.0% (FY2022 to FY2025).
- Across earlier years, Operating Leases came in at $6.44 million in FY2024 (-25.3%), $8.63 million in FY2023 (-20.3%) and $10.82 million in FY2022.
- The Q2 2026 figure is the lowest quarterly Operating Leases in data going back to Q1 2022.
- On a year-over-year basis, Operating Leases has declined for 14 consecutive quarters, with an average decline of 33.4% over the last eight quarters.
- Over the past five years, the year-over-year decline in Operating Leases ranged from 20.0% (Q1 2024) to 47.7% (Q2 2026).
- Per Business Quant, the preceding three quarters came in at $3.41 million (Q1 2026), $4.04 million (Q4 2025) and $4.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.17 Bn | 1,135.76 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 633.70 Bn | 552.23 Bn | 17.26 Bn |
| 3 | AbbVie | 503.94 Bn | 477.06 Bn | 12.70 Bn |
| 4 | Merck | 378.10 Bn | 332.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.72 Bn | 267.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 266.46 Bn | 240.15 Bn | 12.86 Bn |
| 7 | Amgen | 241.07 Bn | 196.47 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.22 Bn | 168.41 Bn | 6.22 Bn |
| 9 | Pfizer | 172.39 Bn | 119.04 Bn | 10.94 Bn |
| 10 | Fulcrum Therapeutics | 283.32 Mn | -60.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.76 Mn |
| Mar 31, 2026 | 3.41 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | 4.66 Mn |
| Jun 30, 2025 | 5.28 Mn |
| Mar 31, 2025 | 5.87 Mn |
| Dec 31, 2024 | 6.44 Mn |
| Sep 30, 2024 | 7.01 Mn |
| Jun 30, 2024 | 7.57 Mn |
| Mar 31, 2024 | 8.11 Mn |
| Dec 31, 2023 | 8.63 Mn |
| Sep 30, 2023 | 9.15 Mn |
| Jun 30, 2023 | 9.65 Mn |
| Mar 31, 2023 | 10.14 Mn |
| Dec 31, 2022 | 10.82 Mn |
| Sep 30, 2022 | 11.50 Mn |
| Jun 30, 2022 | 12.16 Mn |
| Mar 31, 2022 | 12.80 Mn |
API Access
Fulcrum Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=FULC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "FULC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=FULC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();